- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02756468
Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study (PREDIPS)
Background. Pancreatic cancer surgery is associated with very high risk of postoperative morbidity and mortality. Anastomotic leak (AL) is one of the worst complications associated with relevant short and long-term sequelae. Procalcitonin (PCT) is a biomarker used to monitor bacterial infections and guide antibiotic therapy and has been shown to have better predictive value of AL after colorectal surgery than C-reactive protein (CRP) and white blood cell count (WBC).
Purpose. The investigators designed a monocentric pilot study to test if PCT might be a sensitive and reliable marker of AL after pancreatic surgery
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiesteder
-
-
-
Rome, Italien, 00189
- Rekruttering
- Sant'Andrea University Hospital
-
Kontakt:
- Valentina Giaccaglia, MD
- Telefonnummer: 00393397882429
- E-mail: v.giaccaglia@gmail.com
-
Ledende efterforsker:
- Valentina Giaccaglia, MD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- patients undergoing all different kinds of pancreatic surgery
- in elective setting
- for cancer
- with a pancreatic anastomosis performed.
Exclusion Criteria:
- age < 18 years
- pregnant women
- patients undergoing pancreatic surgery for benign disease, other kinds of pancreatic surgery without an anastomosis being performed
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
pts operated for pancreatic cancer
all pts operated of pancreatic resection for cancer in the involved units
|
measuring CRP and PCT in 3rd and 5th POD after pancreatic cancer resection
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Sensitivity of PCT and CRP for anastomotic leak (AL) after pancreatic surgery
Tidsramme: 2 yrs
|
Sensitivity: % of patients corrected identified by the biomarkers having AL; PCT: procalcitonin, CRP: C-reactive protein, AL: anastomic leak
|
2 yrs
|
Specificity of PCT and CRP for anastomotic leak (AL) after pancreatic surgery
Tidsramme: 2 yrs
|
Specificity: % of pts corrected identified by the biomarkers not having AL; PCT: procalcitonin, CRP: C-reactive protein, AL: anastomic leak
|
2 yrs
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
PCT and CRP cuts-off in 3rd POD with a good NPV for AL
Tidsramme: 2 yrs
|
PCT: procalcitonin, CRP: C-reactive protein, NPV: negative predictive value
|
2 yrs
|
PCT and CRP cuts-off in 5th POD with a good NPV for AL
Tidsramme: 2 yrs
|
PCT: procalcitonin, CRP: C-reactive protein, NPV: negative predictive value
|
2 yrs
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PREDIPS
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kræft i bugspytkirtlen
-
Richard HungerMedizinische Hochschule Brandenburg Theodor FontaneAfsluttetVolume-Outcome Relation i Pancreatic Surgery
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuPDAC - Pancreatic Ductal Adenocarcinoma
-
Sun Yat-sen UniversityRekrutteringPDAC - Pancreatic Ductal AdenocarcinomaKina
-
Cedars-Sinai Medical CenterRekrutteringPDAC - Pancreatic Ductal AdenocarcinomaForenede Stater
-
Azienda Ospedaliera Universitaria Integrata VeronaRekrutteringPDAC - Pancreatic Ductal AdenocarcinomaItalien
-
Azienda Ospedaliera Universitaria Integrata VeronaRekrutteringPDAC - Pancreatic Ductal AdenocarcinomaItalien
-
Washington University School of MedicineUniversity of Oklahoma Medical Center; Northwestern University Chicago... og andre samarbejdspartnereAfsluttet
-
Radboud University Medical CenterDutch Cancer SocietyRekrutteringPDAC - Pancreatic Ductal AdenocarcinomaHolland
-
Imperial College LondonThe Leeds Teaching Hospitals NHS Trust; Sheffield Teaching Hospitals NHS... og andre samarbejdspartnereRekrutteringKræft i bugspytkirtlen | PDAC - Pancreatic Ductal AdenocarcinomaDet Forenede Kongerige
-
Andrei IagaruIkke længere tilgængeligCarcinoide tumorer | Islet Cell (Pancreatic NET) | Andre neuroendokrine tumorerForenede Stater